Effect of Non-nucleoside Resistance-Associated Mutations on the Effectiveness of Long-Acting Cabotegravir + Rilpivirine Therapy: Insights From the Real-World RELATIVITY Cohort. [PDF]
Rial-Crestelo D +38 more
europepmc +1 more source
Cumulative exposure to integrase inhibitors and metabolic factors as independent predictors of severe hepatic steatosis in people with HIV. [PDF]
Panza F +11 more
europepmc +1 more source
Prevalence and Severity of Potential Drug-Drug Interactions in People Living with HIV on Antiretroviral Therapy in the United States. [PDF]
Fleming SP +9 more
europepmc +1 more source
Association between infant post-natal prophylaxis regimens and pretreatment HIV drug resistance in infected infants. [PDF]
Inzaule SC +14 more
europepmc +1 more source
HIV-1 integrase inhibitor resistance in viraemic-treated individuals and baseline capsid diversity relevant to future lenacapavir therapy. [PDF]
Abdullahi A +12 more
europepmc +1 more source
Major protease inhibitor drug resistance mutations among patients with virological failure on second-line antiretroviral therapy in Zimbabwe: a retrospective cross-sectional study. [PDF]
Mayini J +7 more
europepmc +1 more source
Application Value of In-House HIV-1 DNA Genotypic Resistance Testing for Individuals with Low-Level Viremia. [PDF]
Zhou Y +9 more
europepmc +1 more source
Patterns of HIV-1 Viral Load Suppression and Drug Resistance During the Dolutegravir Transition: A Population-based Longitudinal Study. [PDF]
Martin MA +22 more
europepmc +1 more source

